Exabis Library
Welcome to the e-CCO Library!
P757: Genotype-serotype interactions shed light on of the pathophysiology inflammatory bowel diseases
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P757: Long-term effectiveness and safety of adalimumab based on Crohn’s disease duration: Results from the PYRAMID registry
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P757: Prevalence of inflammatory bowel disease (IBD) in a colorectal cancer population screening program 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P757: Visceral adiposity and not subcutaneous adiposity or body mass index is more strongly associated with relapse in inflammatory bowel disease
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P758 Ileorectal anastomosis vs. ileal pouch-anal anastomosis for the surgical treatment of ulcerative colitis: A Markov decision analysis 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P758: Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn’s disease (SVEAH CD)
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P758: Elevation in ribosomal and cell cycle gene transcription in macroscopically normal colonic tissue from Icelandic patients with ulcerative colitis
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P758: Impact of co-medication on rates of endoscopic remission: post-hoc analysis of randomised non-inferiority trial of 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P758: Prevalence of moderate to vigorous physical activity and sedentary time in adolescents with inflammatory bowel disease: knowing and doing 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P759 Correlation of quality-of-life components with sexual function scores and disease duration in patients with inflammatory bowel disease 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P759: Incidence and clinical impact of perianal disease in patients with ulcerative colitis: a nationwide population-based study 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P759: MiRNA expression patterns in colon of active and inactive ulcerative colitis
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P759: Perianal Crohn's disease – therapeutic response and anal cancer risk - a single centre retrospective cohort
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P759: Ustekinumab as rescue treatment in therapy-refractory or -intolerant ulcerative colitis
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P760 Differences in persistence of oral mesalazine preparations as monotherapy in patients with ulcerative colitis 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P760: Adalimumab biosimilars versus Azathioprine: indirect comparison of efficacy, safety and persistence in treatment.
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P760: microRNA expression profiling of inflammatory bowel disease
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P760: Monitoring of laboratory parameters during thiopurine maintenance therapy in patients with inflammatory bowel disease: An unnecessary burden?
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P760: The risk of inflammatory bowel disease based on body mass index and waist circumference: a nationwide population-based study 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P761 Illness cognition of Saudi patients with Crohn’s disease 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM